Impact of 3D Cell Culture on Bone Regeneration Potential of Mesenchymal Stromal Cells

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2021 Jan 8

PMID 33413646

Citations 23

Authors

Mesude Bicer

Graeme S Cottrell

Darius Widera

Affiliations

Soon will be listed here.

Abstract

As populations age across the world, osteoporosis and osteoporosis-related fractures are becoming the most prevalent degenerative bone diseases. More than 75 million patients suffer from osteoporosis in the USA, the EU and Japan. Furthermore, it is anticipated that the number of patients affected by osteoporosis will increase by a third by 2050. Although conventional therapies including bisphosphonates, calcitonin and oestrogen-like drugs can be used to treat degenerative diseases of the bone, they are often associated with serious side effects including the development of oesophageal cancer, ocular inflammation, severe musculoskeletal pain and osteonecrosis of the jaw.The use of autologous mesenchymal stromal cells/mesenchymal stem cells (MSCs) is a possible alternative therapeutic approach to tackle osteoporosis while overcoming the limitations of traditional treatment options. However, osteoporosis can cause a decrease in the numbers of MSCs, induce their senescence and lower their osteogenic differentiation potential.Three-dimensional (3D) cell culture is an emerging technology that allows a more physiological expansion and differentiation of stem cells compared to cultivation on conventional flat systems.This review will discuss current understanding of the effects of different 3D cell culture systems on proliferation, viability and osteogenic differentiation, as well as on the immunomodulatory and anti-inflammatory potential of MSCs.

Citing Articles

The Secretome of the Inductive Tooth Germ Exhibits Signals Required for Tooth Development.

Birjandi A, Sharpe P Bioengineering (Basel). 2025; 12(2).

PMID: 40001617 PMC: 11851894. DOI: 10.3390/bioengineering12020096.

Bone mineralisation and glucose metabolism.

Roberts F, Macrae V Curr Opin Endocr Metab Res. 2024; 29:100446.

PMID: 39184263 PMC: 11339533. DOI: 10.1016/j.coemr.2023.100446.

β1-Integrin-Mediated Uptake of Chondrocyte Extracellular Vesicles Regulates Chondrocyte Homeostasis.

Hussain M, Austin-Williams S, Wright T, Dhawan U, Pinto A, Cooper D Int J Mol Sci. 2024; 25(9).

PMID: 38731975 PMC: 11083596. DOI: 10.3390/ijms25094756.

Advantages of Using 3D Spheroid Culture Systems in Toxicological and Pharmacological Assessment for Osteogenesis Research.

Yun C, Kim S, Kim K, Yang M, Byun M, Kim J Int J Mol Sci. 2024; 25(5).

PMID: 38473760 PMC: 10931738. DOI: 10.3390/ijms25052512.

Insights on Three Dimensional Organoid Studies for Stem Cell Therapy in Regenerative Medicine.

Mulaudzi P, Abrahamse H, Crous A Stem Cell Rev Rep. 2023; 20(2):509-523.

PMID: 38095787 PMC: 10837234. DOI: 10.1007/s12015-023-10655-6.

References

Lai R, Arslan F, Lee M, Sze N, Choo A, Chen T . Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010; 4(3):214-22. DOI: 10.1016/j.scr.2009.12.003. View

Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M . Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 1997; 186(4):489-95. PMC: 2199029. DOI: 10.1084/jem.186.4.489. View

Khosla S, Oursler M, Monroe D . Estrogen and the skeleton. Trends Endocrinol Metab. 2012; 23(11):576-81. PMC: 3424385. DOI: 10.1016/j.tem.2012.03.008. View

Johnell O, Kanis J . An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12):1726-33. DOI: 10.1007/s00198-006-0172-4. View

Saito A, Nagaishi K, Iba K, Mizue Y, Chikenji T, Otani M . Umbilical cord extracts improve osteoporotic abnormalities of bone marrow-derived mesenchymal stem cells and promote their therapeutic effects on ovariectomised rats. Sci Rep. 2018; 8(1):1161. PMC: 5773568. DOI: 10.1038/s41598-018-19516-6. View

Kotobuki N, Katsube Y, Katou Y, Tadokoro M, Hirose M, Ohgushi H . In vivo survival and osteogenic differentiation of allogeneic rat bone marrow mesenchymal stem cells (MSCs). Cell Transplant. 2008; 17(6):705-12. DOI: 10.3727/096368908786092793. View

Eleuteri S, Fierabracci A . Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications. Int J Mol Sci. 2019; 20(18). PMC: 6770239. DOI: 10.3390/ijms20184597. View

de Sales Lima M, Rizzato J, Gracindo Marques D, Kitakawa D, da Silva Peralta F, Scherma A . Denosumab Related Osteonecrosis of Jaw: a Case Report. J Oral Maxillofac Res. 2019; 9(4):e5. PMC: 6365882. DOI: 10.5037/jomr.2018.9405. View

Shen G, Zhou H, Zhang H, Chen B, Liu Z, Yuan Y . The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(12):3644-3654. DOI: 10.1016/j.bbadis.2018.09.015. View

10.

Cheng N, Chen S, Li J, Young T . Short-term spheroid formation enhances the regenerative capacity of adipose-derived stem cells by promoting stemness, angiogenesis, and chemotaxis. Stem Cells Transl Med. 2013; 2(8):584-94. PMC: 3726138. DOI: 10.5966/sctm.2013-0007. View

11.

Follin B, Juhl M, Cohen S, Pedersen A, Kastrup J, Ekblond A . Increased Paracrine Immunomodulatory Potential of Mesenchymal Stromal Cells in Three-Dimensional Culture. Tissue Eng Part B Rev. 2016; 22(4):322-9. PMC: 4964752. DOI: 10.1089/ten.TEB.2015.0532. View

12.

Lou S, Lv H, Yin P, Li Z, Tang P, Wang Y . Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int. 2018; 30(1):59-70. DOI: 10.1007/s00198-018-4790-4. View

13.

Charatcharoenwitthaya N, Khosla S, Atkinson E, McCready L, Riggs B . Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res. 2007; 22(5):724-9. DOI: 10.1359/jbmr.070207. View

14.

Wang X, Song Y, Liu Y, Sun Y, Wang Y, Wang Y . Osteogenic Differentiation of Three-Dimensional Bioprinted Constructs Consisting of Human Adipose-Derived Stem Cells In Vitro and In Vivo. PLoS One. 2016; 11(6):e0157214. PMC: 4917247. DOI: 10.1371/journal.pone.0157214. View

15.

Mitchell R, Mellows B, Sheard J, Antonioli M, Kretz O, Chambers D . Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins. Stem Cell Res Ther. 2019; 10(1):116. PMC: 6451311. DOI: 10.1186/s13287-019-1213-1. View

16.

Sun Y, Wang Y, Zhou L, Zou Y, Huang G, Gao G . Spheroid-cultured human umbilical cord-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury in rats. Sci Rep. 2018; 8(1):2518. PMC: 5802716. DOI: 10.1038/s41598-018-20975-0. View

17.

Yang H, Tian W, Wang S, Liu X, Wang Z, Hou L . TSG-6 secreted by bone marrow mesenchymal stem cells attenuates intervertebral disc degeneration by inhibiting the TLR2/NF-κB signaling pathway. Lab Invest. 2018; 98(6):755-772. DOI: 10.1038/s41374-018-0036-5. View

18.

Shekaran A, Sim E, Tan K, Yen Chan J, Choolani M, Reuveny S . Enhanced in vitro osteogenic differentiation of human fetal MSCs attached to 3D microcarriers versus harvested from 2D monolayers. BMC Biotechnol. 2015; 15:102. PMC: 4628389. DOI: 10.1186/s12896-015-0219-8. View

19.

Rampichova M, Chvojka J, Buzgo M, Prosecka E, Mikes P, Vyslouzilova L . Elastic three-dimensional poly (ε-caprolactone) nanofibre scaffold enhances migration, proliferation and osteogenic differentiation of mesenchymal stem cells. Cell Prolif. 2012; 46(1):23-37. PMC: 6496386. DOI: 10.1111/cpr.12001. View

20.

Wang L, Li Y, Chen J, Gautam S, Zhang Z, Lu M . Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol. 2002; 30(7):831-6. DOI: 10.1016/s0301-472x(02)00829-9. View